ABSTRACT
INTRODUCTION: Ataxia and hereditary spastic paraplegia are rare neurodegenerative syndromes. We aimed to determine the prevalence of these disorders in Spain in 2019. PATIENTS AND METHODS: We conducted a cross-sectional, multicentre, retrospective, descriptive study of patients with ataxia and hereditary spastic paraplegia in Spain between March 2018 and December 2019. RESULTS: We gathered data from a total of 1933 patients from 11 autonomous communities, provided by 47 neurologists or geneticists. Mean (SD) age in our sample was 53.64 (20.51) years; 938 patients were men (48.5%) and 995 were women (51.5%). The genetic defect was unidentified in 920 patients (47.6%). A total of 1371 patients (70.9%) had ataxia and 562 (29.1%) had hereditary spastic paraplegia. Prevalence rates for ataxia and hereditary spastic paraplegia were estimated at 5.48 and 2.24 cases per 100 000 population, respectively. The most frequent type of dominant ataxia in our sample was SCA3, and the most frequent recessive ataxia was Friedreich ataxia. The most frequent type of dominant hereditary spastic paraplegia in our sample was SPG4, and the most frequent recessive type was SPG7. CONCLUSIONS: In our sample, the estimated prevalence of ataxia and hereditary spastic paraplegia was 7.73 cases per 100 000 population. This rate is similar to those reported for other countries. Genetic diagnosis was not available in 47.6% of cases. Despite these limitations, our study provides useful data for estimating the necessary healthcare resources for these patients, raising awareness of these diseases, determining the most frequent causal mutations for local screening programmes, and promoting the development of clinical trials.
Subject(s)
Cerebellar Ataxia , Spastic Paraplegia, Hereditary , Male , Humans , Female , Middle Aged , Spastic Paraplegia, Hereditary/epidemiology , Spastic Paraplegia, Hereditary/genetics , Cross-Sectional Studies , Retrospective Studies , Spain/epidemiologyABSTRACT
INTRODUCTION: Ataxia and hereditary spastic paraplegia are rare neurodegenerative syndromes. We aimed to determine the prevalence of these disorders in Spain in 2019. PATIENTS AND METHODS: We conducted a cross-sectional, multicentre, retrospective, descriptive study of patients with ataxia and hereditary spastic paraplegia in Spain between March 2018 and December 2019. RESULTS: We gathered data from a total of 1.809 patients from 11 autonomous communities, provided by 47 neurologists or geneticists. Mean (SD) age in our sample was 53.64 (20.51) years; 920 patients were men (50.8%) and 889 were women (49.2%). The genetic defect was unidentified in 920 patients (47.6%). A total of 1371 patients (70.9%) had ataxia and 562 (29.1%) had hereditary spastic paraplegia. Prevalence rates for ataxia and hereditary spastic paraplegia were estimated at 5.48 and 2.24 cases per 100 000 population, respectively. The most frequent type of dominant ataxia in our sample was SCA3, and the most frequent recessive ataxia was Friedreich ataxia. The most frequent type of dominant hereditary spastic paraplegia in our sample was SPG4, and the most frequent recessive type was SPG7. CONCLUSIONS: In our sample, the estimated prevalence of ataxia and hereditary spastic paraplegia was 7.73 cases per 100 000 population. This rate is similar to those reported for other countries. Genetic diagnosis was not available in 47.6% of cases. Despite these limitations, our study provides useful data for estimating the necessary healthcare resources for these patients, raising awareness of these diseases, determining the most frequent causal mutations for local screening programmes, and promoting the development of clinical trials.
ABSTRACT
The usual clinical profile of Creutzfeldt-Jakob disease (CJD) is that of subacute dementia and intractable myoclonus. Occasionally, some cases present peculiar clinical features. We report on a case of CJD with an unilateral onset showing remarkable neuroimaging features. The patient, aged 72 years, began to suffer from sudden anomia, initially restricted to persons; but in a few weeks it evolved into a global aphasia, right hemiparesis, severe gait disorder, and finally akinetic mutism and intractable myoclonus. He died 11 weeks after onset. Early in the course, an analysis of 14-3-3 protein in CSF was positive. In advanced disease, the EEG showed the typical periodic activity of CJD. FLAIR MRI study showed a mesencephalic and focal cortical hyperintensity. Autopsy was performed and confirmed the diagnosis of CJD with an extensive presence of generalised spongiosis in cerebral grey matter. This case illustrates the usefulness of the life recent paraclinical methods to diagnose CJD in life. New MRI techniques seems to be particularly relevant, as they are not limited to exclude other conditions but can also offer data with validity to a positive diagnosis, like grey matter hyperintensity, that in this case was present also in the midbrain.
Subject(s)
Cerebral Cortex/pathology , Creutzfeldt-Jakob Syndrome/diagnosis , Creutzfeldt-Jakob Syndrome/physiopathology , 14-3-3 Proteins , Aged , Creutzfeldt-Jakob Syndrome/cerebrospinal fluid , Disease Progression , Electroencephalography , Enzyme Inhibitors/cerebrospinal fluid , Humans , Magnetic Resonance Imaging , Male , Paresis/etiology , Tyrosine 3-Monooxygenase/cerebrospinal fluidABSTRACT
La presentación clínica típica de la enfermedad de Creutzfeldt-Jakob (ECJ) es la de una demencia subaguda con mioclonías intratables. Ocasionalmente, algunos casos muestran rasgos clínicos peculiares. Presentamos un caso de ECJ de inicio unilateral que presentó también rasgos destacables en la neuroimagen. El paciente, de 72 años de edad, comenzó con una anomia súbita, inicialmente restringida a personas, que evolucionó en pocas semanas a afasia, hemiparesia derecha, incapacidad para caminar y, finalmente, mutismo acinético y mioclonías intratables. Falleció tras 11 semanas de enfermedad. La determinación de la proteína 14-3-3 en una muestra de LCR tomada precozmente fue positiva. En fases avanzadas, el EEG puso de manifiesto la típica actividad periódica. Las secuencias FLAIR de RM revelaron hiperintensidad cortical focal y mesencefálica. La necropsia confirmó el diagnóstico de ECJ por presencia de espongiosis generalizada en la sustancia gris cerebral. Este caso ilustra la utilidad de los recientes métodos de laboratorio para el diagnóstico en vida de la ECJ. En particular la RM presenta datos no ya de exclusión sino de diagnóstico positivo, como la hiperintensidad de la sustancia gris, que en este caso llegó a verse en el mesencéfalo. (AU)
Subject(s)
Aged , Male , Humans , Tyrosine 3-Monooxygenase , Disease Progression , Paresis , Cerebral Cortex , Creutzfeldt-Jakob Syndrome , Magnetic Resonance Imaging , Electroencephalography , Enzyme Inhibitors , Tyrosine 3-MonooxygenaseSubject(s)
Exanthema/diagnosis , Fever/diagnosis , HIV Infections/diagnosis , HIV-1 , Meningism/diagnosis , Acute Disease , Adult , Diagnosis, Differential , Female , HumansABSTRACT
No disponible
